ORANGE COUNTY EARNINGS

Allergan Inc.: The Irvine eye care company, which took $182.4 million in charges related to two stock transactions, reported a first-quarter loss of $122.2 million, or $1.87 a share, compared to a first-quarter profit last year of $17.8 million, or 27 cents a share. Quarterly sales rose 5% to $269.3 million this year from $256.2 million.

Allergan said it took a one-time charge of $171.4 million, or $2.62 a share, relating to a dividend to Allergan shareholders for its March spinoff of Allergan Specialty Therapeutics Inc. research and development company. It also took an $11-million charge, or 12 cents a share, for the value of stock in another company contributed to the Allergan Foundation, a recently formed nonprofit corporation.